In the NTG-induced migraine model, Chuanxiong Qingnao Granules significantly attenuated neuroinflammatory responses by inhibiting the PI3K–Akt signaling pathway [26], supporting the therapeutic potential of targeting this pathway in alleviating NTG-induced migraine. Here, AKT1 is linked to migraine disorder.